Pelancong
Homoseksual
Pengguna obat suntikan
Penderita dengan kelainan faktor pembekuan
Penderita penyakit hati kronik
Pengelola jasa boga
Pekerja institusi perawatan anak
Pekerja di institusi kesehatan
Anak sekolah
Pekerja yang berhubungan dengan sampah
Virus Hepatitis A :
Asimptomatik/simptomatik,anikterik,ikterik
Demam ringan
Gejala saluran pernapasan danatau saluran cerna
Hepatitis asimptomatik
Subklinik atau tidak nyata
Subklinik : kelainan fungsi hati ,yaitu peningkatan
aminotransferase serum
Infeksi tak nyata : pemeriksaan serologik
Hepatitis simptomatik
Masa inkubasi
Waktu antara terpapar virus dan peningkatan nilai
aminotransferase : 18-50 hari (rata-rata 28 hari)
HAV-specific
IgM
Excretion
of HAVAg
in faeces
1 2 3 4 5 6 7 8 9 weeks
HEPATITIS B
EPIDEMIOLOGI
Individuals with
Intravenous
multiple
drug users
sexual partners
Healthcare
workers Prisoners and other
institutionalised people
Beberapa teori yang memungkinkan terjadinya
penularan infeksi HBV dari ibu ke anak
HBsAg
ANTI-HBeAb
ANTI-HBsAb
HBcAg
and
HBeAg
1 2 3 4 5 6 7 8 9 MONTHS
Acute Hepatitis B Virus Infection with Recovery
Typical Serologic Course
Symptoms
HBeAg anti-HBe
Total anti-HBc
Titer
0 4 8 12 16 20 24 28 32 36 52 100
Weeks after exposure
Progression to Chronic Hepatitis B Virus
Infection Typical Serologic Course
Acute Chronic
(6 months) (years)
HBeAg anti-HBe
HBsAg
Total anti-HBc
Titer
IgM anti-HBc
0 4 8 12 16 20 24 28 32 36 52
Compensated
Resolution Stabilisation Cirrhosis
Mild
Raised ALT and/or AST only
More severe
Raised ALT/AST and raised bilirubin
Improvement in hepatic
necroinflammatory
disease
Reduction in long-term sequelae of
HBV-associated liver disease
(cirrhosis, hepatocellular carcinoma)
How to Monitor?
TREATMENT
REHABILITATION
TREATMENT OF HEPATITIS
REDUCTION OF EXPOSURE
VIRAL ERADICATION